Peter Meinhold, Co-Founder & CTO of Provivi. Peter Meinhold, is the Co-Founder & CTO of Provivi, a groundbreaking science-based company creating scalable, safer insect control technology that will improve the quality of life for all humans and our world.
Keira Havens, Industry and Regulatory Affairs Manager at Pivot Bio. Keira Havens has been deeply involved in synthetic biology as a scientist, an entrepreneur, a communicator, and a thought leader. Her work has engaged all facets of the synthetic biology economy in the pursuit of beautiful biotechnology - well designed, elegant solutions [...]
Stephanie Simon is the Admissions Manager at Y Combinator. Prior to YC, she was a software engineer and startup founder. Her job involves reading applications, interviewing founders, and building software for admissions.
Brandon Clark, Vice President at Silicon Valley Bank. Brandon Clark manages a portfolio of life science and healthcare companies with a focus on digital health and synthetic biology at Silicon Valley Bank.
Isha Datar, Executive Director of New Harvest. Isha has been pioneering the field of cellular agriculture since 2009, when she began a deep-dive investigation into the technical challenges and opportunities involved in producing cultured meat. In 2010 Isha published "Possibilities for an in-vitro meat production system" in the food science journal Innovative Food [...]
Jeff Klunzinger, Co-founder of OS Fund. Jeff is the Co-founder of OS Fund. He is focused on discovering and empowering entrepreneurs who are working on advancements that are fundamental to the future of humanity. Jeff has nearly two decades of experience in the investment business. He was a founding member and CFO [...]
Edward Perello, Principle of Arkurity. Edward Perello serves as Principle of Arkurity, and has expertise in genome editing and synthetic biology, public communications, biotechnology commercialisation and biosecurity policy. His research interests include the governance and policy of biotechnology, in particular, the oversight of human genome editing, non-state use of biological weapons, and [...]
Zachary Sun, CEO of Tierra Biosciences. Zachary Sun has been developing fundamental synthetic biology technologies since 2006, and has published work on MAGE genomic engineering in Nature and on a cell-free prototyping environment in eLife. The latter forms the basis for Tierra Biosciences (formerly Synvitrobio). Sun is a NDSEG Fellow, a DARPA [...]
Matthew Ocko, Managing Partner at DCVC (Data Collective). Matt co-founded DCVC because he watched too much Star Trek while growing up and was persuaded that a future of abundance and freedom from need, and technology in the service of human empowerment, made a lot of sense. Reading the biographies of entrepreneurs like [...]
Leslie Mitchell, Co-founder of Neochromosome. Leslie Mitchell is currently a postdoctoral fellow at NYU Langone Health and co-founder of a biotech startup, Neochromosome developing new human therapies using genome writing technology. She has worked extensively on chromosome and genome engineering in both yeast and mammalian systems and helps lead the international Synthetic [...]
